RGIN Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (11 Apr 2024 @ 10:16):

Stats
Today's Volume	23 000.00
Average Volume	29 934.00
Market Cap	767 415
EPS	$-0.00196 ( 2023-03-30 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.500
ATR14	$0 (0.00%)

Volume Correlation

Long: -0.12 (neutral)

Short: 0.00 (neutral)

Signal:(23.342) Neutral

Regenicin, Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Regenicin, Inc. Correlation - Currency/Commodity

0.00
( neutral )

Regenicin, Inc. Financials

Annual	2022
Revenue:	$0
Gross Profit:	$-601 179 (0.00 %)
EPS:	$-0.00450

Q3	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$0

Q2	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$0

Q2	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-0.00200

Financial Reports:

No articles found.

Regenicin, Inc.

Regenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes. The company's product portfolio includes NovaDerm, a multi-layered tissue-engineered living skin and cultured skin substitute product for the treatment of burns; and TempaDerm to treat smaller wound areas on patients, such as ulcers. Its products are used to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds, and various plastic surgery procedures. The company was formerly known as Windstar, Inc. and changed its name to Regenicin, Inc. in July 2010. Regenicin, Inc. was incorporated in 2007 and is headquartered in Little Falls, New Jersey.